BELGRAVIA CAPITAL Changes Name to “BELGRAVIA HARTFORD” and Announces Continuance under the Business Corporations Act (British Columbia) Dec 19, 2019 09:00AM
BELGRAVIA Corporate Update Dec 19, 2019 09:00AM
Belgravia Provides Corporate Update Nov 1, 2019 08:18AM
BELGRAVIA Provides Legal Update Nov 1, 2019 08:18AM
BELGRAVIA provides Corporate Update Sep 10, 2019 08:18AM


Jul 11, 2019 04:00PM BELGRAVIA Corporate Update
Jun 27, 2019 02:54PM BELGRAVIA announces results of Annual Meeting
Apr 25, 2019 08:00AM Belgravia Capital: Corporate Update
Oct 24, 2018 07:00AM BELGRAVIA CAPITAL provides update on Normal Course Issuer Bid
Oct 19, 2018 07:00AM BELGRAVIA CAPITAL to Proceed with Normal Course Issuer Bid
Oct 17, 2018 07:00AM BELGRAVIA CAPITAL corporate update
Sep 20, 2018 08:00AM BELGRAVIA CAPITAL engages Haywood Securities and hosts Investor Update conference call
Sep 17, 2018 02:39PM BELGRAVIA provides update on Tartisan AGM
Sep 13, 2018 07:00AM BELGRAVIA CAPITAL to host Investor Update conference call
Sep 6, 2018 07:00AM BELGRAVIA CAPITAL INTERNATIONAL announces that ISS Recommends that all Tartisan shareholders Use Only Belgravia’s GREEN proxy or GREEN VIF to Vote on All Matters
Sep 4, 2018 07:00AM BELGRAVIA CAPITAL files complaint with OSC against Mark Appleby of Tartisan Nickel and others for what it believes are multiple breaches of the Securities Act
Aug 28, 2018 07:00AM BELGRAVIA CAPITAL files request that Canadian Securities Exchange review Tartisan Nickel’s ability to remain listed and offers Shareholders alternatives
Aug 24, 2018 07:05AM BELGRAVIA provides update on its Dermatology Subsidiary
Aug 24, 2018 07:00AM BELGRAVIA CAPITAL Update on Proxy Solicitation of Tartisan Nickel
Aug 7, 2018 07:00AM BELGRAVIA Intends to Replace the Board of Tartisan Nickel for Failure to Perform
Jul 18, 2018 08:09AM BELGRAVIA corporate update
Jun 18, 2018 07:00AM Belgravia Dermatology Completes Identification of Initial Drug Targets Within the Skin Endocannabinoid System and Also Identifies Bio Markers for Pre Clinical Work in Acne
May 30, 2018 07:00AM BELGRAVIA CAPITAL completes acquisition of interest in R&D Pharma Corp., a Canadian corporation building a vertically integrated medical cannabis business in Jamaica
May 11, 2018 07:00AM Belgravia Completes Transition of ICP Organics to Dermatology Product Development, Renames ICP Organics to Belgravia Dermatology Inc., and Appoints Sidney Himmel Director of Belgravia Dermatology
Apr 27, 2018 07:00AM Belgravia Announces Results of Annual Meeting
Apr 18, 2018 07:00AM Belgravia Appoints Dr. Sam Hanna Chief Medical Officer of Cannabis Dermatology Division
Mar 12, 2018 07:00AM BELGRAVIA CAPITAL adds to expertise in corporate development and expands medical advisory committee
Feb 28, 2018 07:00AM BELGRAVIA CAPITAL signs Binding Letter of Intent with R&D Pharma Corp., a developer of a vertically integrated medicinal cannabis business in Jamaica, to invest Canadian $1,000,000
Jan 25, 2018 07:00AM BELGRAVIA CAPITAL INTERNATIONAL and Fanlogic Commence Design of Blockchain Loyalty Program for the Global Cannabis Industry
Jan 10, 2018 07:00AM BELGRAVIA CAPITAL INTERNATIONAL receives cash payment, appoints renowned Dermatologist as special advisor to ICP Organics, and provides updates on additional blockchain developments
Jan 4, 2018 07:00AM BELGRAVIA CAPITAL INTERNATIONAL announces LOI with R&D Pharma Corp.
Dec 5, 2017 09:03AM BELGRAVIA CAPITAL Corporate Update